Mirae Asset Global Etfs Holdings »

Nektar Therapeutics shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $127k 98k 1.30

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Global X Fds X Russell 2000 E (RSSL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Cameco Corporation (CCJ)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Intuitive Surgical Com New (ISRG)
Netflix (NFLX)
Trane Technologies SHS (TT)
United Rentals (URI)
Eaton Corp SHS (ETN)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Nektar Therapeutics

Deep Track Capital
BlackRock
BlackRock
Vanguard Group
Eventide Asset Management
Samlyn Capital
Citadel Advisors
PRIMECAP Management Company
Acadian Asset Management
Nantahala Capital Management
TCG Crossover Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Jacobs Levy Equity Management

View all funds holding Nektar Therapeutics